Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse

Annals of the New York Academy of Sciences

Volumn 1107, Issue , 2007, Pages 155-167

  Achiron, Anat ^a,b   Feldman, Anna ^a   Mandel, Mathilda ^a,b   Gurevich, Michael ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acute relapse; Apoptosis; Gene expression; Multiple sclerosis

Indexed keywords

ANTIGEN; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BINDING PROTEIN; CASPASE 10; CASPASE 2; CASPASE 8; CASPASE 9; CD3E ANTIGEN; COMPLEMENTARY DNA; HUMAN T CELL LEUKEMIA VIRUS TYPE I BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; MESSENGER RNA;

ADULT; APOPTOSIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; RELAPSE; REMISSION; STATISTICAL SIGNIFICANCE; ACUTE DISEASE; ARTICLE; CLASSIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; RECURRENT DISEASE;

HUMAN T-LYMPHOTROPIC VIRUS 1;

ACUTE DISEASE; ADULT; APOPTOSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MULTIPLE SCLEROSIS; RECURRENCE; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 34648835408     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1381.017     Document Type: Conference Paper

References (32)

1. HAUSER, S.L. & J.R. OKSENBERG. 2006. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52: 61-76.
2. DENG, X., A. LJUNGGREN-ROSE, K. MAAS & S. SRIRAM. 2005. Defective ATM-p53-mediated apoptotic pathway in multiple sclerosis. Ann. Neurol. 58: 577-584.
3. PRASAD, K.V., B.S. PRABHAKAR. 2003. Apoptosis and autoimmune disorders. Autoimmunity 36: 323-330.
4. SHARIEF, M.K., M. DOUGLAS, M. NOORI & Y.K. SEMRA. 2002. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis. J. Neuroimmunol. 125: 155-162.
5. SHARIEF, M.K., H. MATTHEWS & M.A. NOORI. 2003. Expression ratios of the Bcl-2 family proteins and disease activity in multiple sclerosis. J. Neuroimmunol. 134: 158-165.
6. WAICZIES, S., A. WEBER, J.D. LUNEMANN, et al. 2002. Elevated Bcl-X(L) levels correlate with T cell survival in multiple sclerosis. J. Neuroimmunol. 126: 213-220.
7. SARESELLA, M., I. MARVENTANO, L. SPECIALE, et al. 2005. Programmed cell death of myelin basic protein-specific T lymphocytes is reduced in patients with acute multiple sclerosis. J. Neuroimmunol. 166: 173-179.
8. OKUDA, Y., B.R. APATOFF & D.N. POSNETT. 2006. Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis. J. Neuroimmunol. 171: 163-70.
9. SATOH, J., M. NAKANISHI, F. KOIKE, et al. 2005. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol. Dis. 18: 537-550.
10. SEMRA, Y.K., O.A. SEIDI & M.K. SHARIEF. 2002. Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins. J. Neuroimmunol. 122: 159-166.
11. SHARIEF, M.K., M.A. NOORI, M.R. DOUGLAS & Y.K. SEMRA. 2002. Upregulated surviving expression in activated T lymphocytes correlates with disease activity in multiple sclerosis. Eur. J. Neurol. 9: 503-510.
12. LOPATINSKAYA, L., A.H. VAN BOXEL-DEZAIRE, F. BARKHOF, et al. 2003. The development of clinical activity in relapsing-remitting MS is associated with a decrease of FasL mRNA and an increase of Fas mRNA in peripheral blood. J. Neuroimmunol. 138: 123-131.
13. CHARLES POSER, C.M. & V. BRINAR. 2001. Diagnostic criteria for multiple sclerosis. Clin. Neurol. Neurosurg. 103: 1-11.
14. KURTZKE, J.F.. 1983. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
15. VAUX, D.L., S. CORY & J.M. ADAMS. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442.
16. KELEKAR, A. & C.B. THOMPSON. 1998. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell. Biol. 8: 324-330.
17. SETKOVA, J., E. MATALOVA, P.T. SHARPE, et al. 2007. Primary enamel knot cell death in Apaf-1 and caspase-9- deficient mice. Arch. Oral Biol. 52: 15-19.
18. CHRISTOPH, F., S. WEIKERT, C. KEMPKENSTEFFEN, et al. 2006. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications. Clin. Cancer Res. 12: 5040-5046.
19. TWIDDY, D., D.G. BROWN, C. ADRAIN, et al. 2004. Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1/caspase-9 apoptosome complex. J. Biol. Chem. 279: 19665-19682.
20. KINOSHITA, T., Y. WANG, M. HASEGAWA, et al. 2005. PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1beta secretion. Biol. Chem. 280: 21720-21725.
21. GIEBEL, J., C. WOENCKHAUS, M. FABIAN & F. TOST. 2005. Age-related differential expression of apoptosis-related genes in conjunctival epithelial cells. Acta Ophthalmol. Scand. 83: 471-476.
22. HITOSHI, Y., J. LORENS, S.I. KITADA, et al. 1998. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity 8: 461-471.
23. SONG, Y. & C.O. JACOB. 2005. The mouse cell surface protein TOSO regulates Fas/Fas ligand-induced apoptosis through its binding to Fas-associated death domain. J. Biol. Chem. 280: 9618-9626.
24. BALLOU, L.M., M.E. CROSS, S. HUANG, et al. 2000. Differential regulation of the phosphatidylinositol 3-kinase/Akt and p70 S6 kinase pathways by the alpha(1 A)-adrenergic receptor in rat-1 fibroblasts. J. Biol. Chem. 275: 4803-4809.
25. LEE, M.J., S. THANGADA, J.H. PAIK, et al. 2001. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol. Cell. 8: 693-704.
26. DE VALCK, D., D.Y. JIN, K. HEYNINCK, et al. 1999. The zinc finger protein A20 interacts with a novel anti-apoptotic proteinwhich is cleaved by specific caspases. Oncogene 18: 4182-4190.
27. OZES, O.N., L.D. MAYO, J.A. GUSTIN, et al. 1999. NF-kappa-β activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85.
28. ROMASHKOVA, J.A. & S.S. MAKAROV. 1999. NF-kappa-β is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 86-90.
29. FRANCOIS, F. & M.L. GRIMES. 1999. Phosphorylation-dependent Akt cleavage in neural cell in vitro reconstitution of apoptosis. J. Neurochem. 73: 1773-1776.
30. BRADY, S.C., L.A. ALLAN & P.R. CLARKE. 2005. Regulation of caspase 9 through phosphorylation by protein kinase C zeta in response to hyperosmotic stress. Mol. Cell Biol. 25: 10543-10555.
31. SANCHEZ-VALDEPENAS, C., C. PUNZON, B. SAN-ANTONIO, et al. 2007. Differential regulation of p65 and c-Rel NF-kappa-β transactivating activity by Cot, protein kinase C zeta and NIK protein kinases in CD3/CD28 activated T cells. Cell. Signal 19: 528-537.
32. NGUYEN, H., S. SANKARAN & S. DANDEKAR. 2006. Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes. Virology 354: 58-68.